MedTrace Logo

Effects of Carnitine Supplementation on Liver and Muscle

NCT03439917 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2021-11-30

No results posted yet for this study

Summary

It will be evaluated whether carnitine, a dietary supplement, reduces liver fat and improves metabolism in individuals who have a high concentration of fat within their liver. Participants will be given either Carnitine or placebo, together with a meal replacement milkshake twice daily for 6 months.

Conditions

Interventions

DIETARY_SUPPLEMENT

L-Carnitine tartrate

2g L-Carnitine tartrate as a powder consumed twice a day

DIETARY_SUPPLEMENT

Meal Replacement Drink

325ml dairy-based meal replacement drink ('Slimfast' trademark of KSF Acquisition UK Ltd) consumed twice a day

DIETARY_SUPPLEMENT

Maltodextrin

2g Maltodextrin powder packaged to mimic carnitine powder consumed twice a day

Sponsors & Collaborators

  • Nottingham University Hospitals NHS Trust

    collaborator OTHER

  • National Institute for Health Research, United Kingdom

    collaborator OTHER_GOV

  • University of Nottingham

    lead OTHER

Principal Investigators

  • Guru Aithal, MD, PhD · University of Nottingham

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-02
Primary Completion
2020-08-30
Completion
2021-11-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03439917 on ClinicalTrials.gov